Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
got the first back in 2020; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (got the first back in 2020). On an unknown date, the patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: got the first back in 2020). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 31-JUL-2025 Pharmacist wanted to know how to proceed with the second dose of Shingrix after a wife and her husband got the first back in 2020. Healthcare professional mentioned that the patient could have received the first dose in another facility than the one with the zip code provided. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.; Sender's Comments: US-GSK-US2025098983: